| Literature DB >> 22701359 |
Makiko Tani1, Hiroshi Morimatsu, Fumiaki Takatsu, Kiyoshi Morita.
Abstract
Little is known on the clinical effects of chloride on critically ill patients. We conducted this retrospective, observational study in 488 critically ill patients to investigate the incidence of chloride abnormalities, effects of hypochloremia in acid-base disorders, and association between chloride and clinical outcome. The study involved retrieval of arterial blood gas analyses, biochemical and demographical data from electrical records as well as quantitative acid-base analyses. For statistical analysis, the patients were stratified into three groups according to their chloride level (normal range: 98-106 mEq/L). The distribution of chloride levels was hyperchloremia 16.6%, normochloremia 74.6%, and hypochloremia 8.8%. The hypochloremic group was significantly alkalemic (P < 0.0001) and has significantly higher apparent strong ion difference (SIDa) (P < 0.0001) compared to the two other groups. The hypochloremic group had significantly longer stays in the ICU and hospital (P < 0.0001) with higher mortality (P < 0.0001). However, multiple regression analysis showed that chloride was not an independent factor of poorer outcome. In conclusion, the acid-base characteristics of the hypochloremic patients were alkalemia coexisting with higher SIDa. And although it was not an independent prognostic factor, hypochloremia was related to poorer outcome in critically ill settings.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22701359 PMCID: PMC3373177 DOI: 10.1100/2012/474185
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Flow diagram of patients selection during the study.
Patient demographics and clinical variables.
| Characteristics |
|
|---|---|
|
| 488 |
| Age, years, | 61.8 ± 16.2 |
| Sex, male, | 293 (60.0) |
| APACHE II score | 12.1 ± 4.4 |
| Reason for ICU admission | |
| Postoperative, | 443 (90.8) |
| Sepsis, | 16 (3.3) |
| Respiratory failure, | 9 (1.8) |
| Cardiogenic shock, | 8 (1.6) |
| Hypovolemic shock, | 3 (0.6) |
| Miscellaneous, | 25 (5.1) |
| Type of admission, | |
| Surgical | 443 (90.8) |
| Medical | 45 (9.2) |
| ICU stay, days | 7.4 ± 9.6 |
| Hospital stay, days | 41.8 ± 39.7 |
| ICU mortality, | 15 (3.0) |
| Hospital mortality, | 28 (5.7) |
APACHE II score: acute Physiology and Chronic Health Evaluation II score; ICU: intensive care unit.
Acid-base variables in hyperchloremic, normochloremic, and hypochloremic patients.
| Variables | Hyperchloremia | Normochloremia | Hypochloremia |
|
|---|---|---|---|---|
| pH | 7.41 ± 0.04 | 7.42 ± 0.035 | 7.44 ± 0.065 | <.0001 |
| PaCO2, mmHg | 38.0 ± 4.8 | 40.7 ± 5.0 | 42.3 ± 7.3 | <.0001 |
| Bicarbonate, mmol/L | 23.8 ± 2.2 | 26.0 ± 2.4 | 28.5 ± 5.0 | <.0001 |
| AG, mmol/L | 7.0 ± 3.3 | 7.9 ± 2.9 | 11.3 ± 6.9 | <.0001 |
| SBE, mmol/L | −0.16 ± 2.1 | 2.0 ± 2.3 | 4.4 ± 5.1 | <.0001 |
| Sodium, mmol/L | 135.7 ± 3.1 | 132.6 ± 3.4 | 130.0 ± 7.0 | <.0001 |
| SIDa, mmol/L | 30.5 ± 3.1 | 33.9 ± 3.5 | 38.2 ± 4.4 | <.0001 |
| SIDe, mmol/L | 26.9 ± 0.3 | 29.0 ± 0.2 | 32.1 ± 0.5 | <.0001 |
| SIG, mol/L | 3.5 ± 2.8 | 4.8 ± 2.7 | 6.2 ± 3.4 | <.0001 |
| Albumin, g/dL | 2.97 ± 0.57 | 2.78 ± 0.47 | 3.0 ± 0.08 | <.0001 |
| Phosphate, mmol/L | 1.1 ± 0.3 | 1.00 ± 0.3 | 1.2 ± 0.5 | <.0001 |
| Lactate, mmol/L | 1.4 ± 0.99 | 1.2 ± 0.8 | 2.2 ± 4.4 | <.0001 |
| Lactate + Chloride, | 110.1 ± 2.1 | 103.6 ± 2.6 | 96.1 ± 6.3 | <.0001 |
| mmol/L |
AG: anion gap; SBE: standard base excess; SIDa: apparent strong ion difference; SIDe: effective strong ion difference; SIG: strong ion gap.
Length of stay and mortality in hyperchloremic, normochloremic, and hypochloremic patients.
| Variables | Hyperchloremia | Normochloremia | Hypochloremia |
|
|---|---|---|---|---|
| ICU stay, days | 4.4 ± 2.5 | 7.3 ± 9.6 | 14.3 ± 13.3 | <.0001 |
| Hospital stay, days | 28.4 ± 19.5 | 41.4 ± 37.3 | 70.5 ± 65.7 | <.0001 |
| ICU mortality, % | 2/81 = 2.5 | 7/364 = 1.9 | 6/43 = 14.0 | <.0001 |
| Hospital mortality, % | 3/81 = 3.7 | 14/364 = 3.8 | 10/43 = 23.3 | <.0001 |
ICU: intensive care unit.
Comparison of variables in surviving and nonsurviving patients in the hospital.
| Variables | Nonsurvivors | Survivors |
|
|---|---|---|---|
| APACHE II score | 18.1 ± 7.5 | 11.7 ± 3.9 | <.0001 |
| Sex, male (%) | 60.7 | 60.7 | 1.0000 |
| Body weight, kg | 53.2 ± 11.7 | 57.9 ± 12.6 | 0.0561 |
| Height, cm | 159.1 ± 1.8 | 159.8 ± 0.43 | 0.7302 |
| Age, years | 57.3 ± 3.0 | 62.1 ± 0.8 | 0.127 |
| Medical admission, % | 42.86 | 7.4 | <.0001 |
| pH | 7.41 ± 0.076 | 7.42 ± 0.037 | 0.3978 |
| PaCO2, mmHg | 38.3 ± 5.2 | 40.5 ± 5.3 | 0.0331 |
| Sodium, mmol/L | 131.1 ± 4.7 | 133.0 ± 4.0 | 0.0166 |
| Potassium, mmol/L | 3.9 ± 0.6 | 3.8 ± 0.38 | 0.0298 |
| Calcium, mmol/L | 1.1 ± 0.098 | 1.1 ± 0.064 | 0.0001 |
| Albumin, g/dL | 2.75 ± 0.65 | 2.83 ± 0.51 | 0.41 |
| Chloride, mmol/L | 99.8 ± 5.7 | 102.9 ± 4.2 | 0.0002 |
| Bicarbonate, mmol/L | 24.4 ± 4.1 | 26.0 ± 2.8 | 0.0059 |
| Lactate, mmol/L | 2.9 ± 5.1 | 1.2 ± 0.9 | <.0001 |
| SBE, mmol/L | 0.33 ± 4.6 | 1.9 ± 3.7 | 0.0043 |
| SIDa, mmol/L | 33.4 ± 4.5 | 33.7 ± 3.9 | 0.6904 |
| AG, mmol/L | 10.7 ± 6.5 | 7.9 ± 3.3 | <.0001 |
| Hematocrit, % | 30.2 ± 5.4 | 32.6 ± 4.8 | 0.0109 |
| Glucose, mg/dL | 159.8 ± 66.6 | 149.0 ± 37.6 | 0.1634 |
APACHE II score: Acute Physiology and Chronic Health Evaluation II score; SBE: standard base excess; SIDa: apparent strong ion difference; AG: anion gap.
Logistic regression model for survival.
| Variables | Coefficient | Odds ratio |
|
|---|---|---|---|
| (95% confidence interval) | |||
| APACHE II score | 0.1821 | 1.200 (1.081–1.331) | 0.000619 |
| Medical admission | 0.9544 | 2.597 (1.437–4.693) | 0.001573 |
| PaCO2 | 0.01246 | 1.012 (0.890–1.151) | 0.8497 |
| Sodium | −0.1104 | 0.8954 (0.7380–1.086) | 0.2629 |
| Potassium | 0.7253 | 2.065 (0.6817–6.257) | 0.1996 |
| Chloride | 0.05399 | 1.055 (0.8944–1.246) | 0.5227 |
| Calcium | −6.124 | 0.00219 (2.170 × 10−6–2.209) | 0.08267 |
| Bicarbonate | −0.03445 | 0.9661 (0.7341–1.272) | 0.8058 |
| Lactate | 0.5559 | 1.743 (1.138–2.671) | 0.01069 |
| Hematocrit | −0.00603 | 0.9940 (0.8931–1.106) | 0.9120 |
Comparison of variables between medical and surgical admissions.
| Variables | Medical | Surgical |
|
|---|---|---|---|
| Age, years | 59.4 ± 15.6 | 62.1 ± 16.2 | 0.2827 |
| Sex, male (%) | 43.5% | 38.9% | 0.6346 |
| pH | 7.43 ± 0.06 | 7.42 ± 0.03 | 0.226 |
| PaCO2, mmHg | 40.8 ± 7.4 | 40.4 ± 5.0 | 0.5504 |
| Sodium, mmol/L | 133.0 ± 7.1 | 132.9 ± 3.6 | 0.8201 |
| Potassium, mmol/L | 3.88 ± 0.58 | 3.75 ± 0.377 | 0.041 |
| Chloride, mmol/L | 98.8 ± 6.4 | 103.1 ± 3.9 | <.0001 |
| Calcium, mmol/L | 1.12 ± 0.10 | 1.13 ± 0.06 | 0.3973 |
| Bicarbonate, mmol/L | 26.7 ± 4.8 | 25.8 ± 2.7 | 0.0354 |
| Lactate, mmol/L | 1.9 ± 4.0 | 1.3 ± 1.0 | 0.0073 |
| Glucose, mg/dL | 150.7 ± 58.9 | 149.5 ± 37.4 | 0.8572 |
| Hematocrit, % | 31.6 ± 6.5 | 32.6 ± 4.7 | 0.1903 |
| Albumin, g/dL | 2.85 ± 0.46 | 2.82 ± 0.52 | 0.6877 |
| Total bilirubin, mg/dL | 2.1 ± 2.9 | 1.4 ± 1.7 | 0.0138 |
Figure 2Relationship between chloride and APACHE II score. The solid line represents the linear regression line, and the dotted line represents the 95% confidence band. (a) Total study population. (b) Surgical patients. (c) Medical patients.